Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Jul 2008

Sidelmann Johannes J, Bladbjerg Else-Marie, Gram Jørgen, Münster Anna-Marie B, Jespersen Jørgen

Abstract excerpt

Reduced concentration of tissue factor pathway inhibitor is a risk factor for development of deep venous thrombosis, whereas elevated concentrations of tissue factor pathway inhibitor are observed in patients with acute myocardial infarction and disseminated intravascular coagulation. Presently, we studied the association between inflammation, endothelial cell perturbation, fibrin degradation and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to C-Reactive Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endothelial Cells

Share to Fibrin Fibrinogen Degradation Products

Share to Inflammation

Share to Lipoproteins

Share to Venous Thrombosis

Share to von Willebrand Factor

Source

Identifiers

PMID: 18600090
DOI: 10.1097/MBC.0b013e3283049639

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis.PMID 18600090Read ↗

Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.Semantic proximity Read ↗

Plasma fibrinolysis, inflammatory markers, and postthrombotic syndrome: preliminary findings from the Kids-DOTT BiobankSemantic proximity Read ↗

Genetic determinants of tissue factor pathway inhibitor plasma levels.Semantic proximity Read ↗

Association of Asn221Ser mutation in tissue factor pathway inhibitor-beta with plasma total tissue factor pathway inhibitor level.Semantic proximity Read ↗

Circulating microRNA expression and their target genes in deep vein thrombosisSemantic proximity Read ↗

Tissue factor pathway inhibitor binds to platelet thrombospondin-1.Semantic proximity Read ↗

Factor VII-activating protease in patients with acute deep venous thrombosis.Semantic proximity Read ↗

Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosisSemantic proximity Read ↗

Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.Semantic proximity Read ↗

4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.Semantic proximity Read ↗

Low protein Z levels and risk of occurrence of deep vein thrombosis.Semantic proximity Read ↗

Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.